Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Software Engineer, Infrastructure
San Francisco office · Posted on Nov 25, 2025
Scientist, Partnerships
San Francisco office · Posted on Nov 25, 2025
VP, Business Development
San Francisco office · Posted on Nov 18, 2025
Scientific Program Manager
San Francisco office · Posted on Nov 6, 2025
Product Designer
San Francisco office · Posted on Jun 30, 2025
AI Research Lead
San Francisco office · Posted on Jun 30, 2025
Software Engineer, Product
San Francisco office · Posted on Jun 30, 2025
Scientist, Computational Biology
San Francisco office · Posted on Jun 30, 2025
Scientist, Antibody Engineering
San Francisco office · Posted on Jun 30, 2025
AI Research Scientist
San Francisco office · Posted on Sep 5, 2024
AI Research Engineer
San Francisco office · Posted on Sep 5, 2024
"Insert Job You Excel At"
San Francisco office · Posted on Sep 5, 2024
Explore similar companies to Chai Discovery
Red Queen Bio
AI-enabled biosecurity.
Bindwell
Building better pesticides with AI.
Profluent
Grounded in nature, authored by AI.
Science
A brighter tomorrow enabled by neural engineering.
Cradle
Engineer better proteins, faster.
Lila Sciences
Building scientific superintelligence.
Manifold Bio
Tissue-targeted medicines, designed in vivo.
Valthos
Next-generation biodefense.
Convoke
AI-native OS for drug development.



















